Patent · US Expired

Compositions and methods for enhancing phagocytosis or phagocyte activity

US8198020B2 · kind B2 · utility

16Cited by
4References
59Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 23, 2004
Grant dateJun 12, 2012
Priority date
Expiry dateJan 25, 2026

Classification

  • Technology area (CPC B)Performing Operations; Transporting
  • CPC primaryB82Y5/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a system for enhancing clearance or destruction of undesirable cells or noncellular molecular entities by tagging such cells or noncellular molecular entities with a marker that targets the cells or noncellular molecular entities for phagocytosis (phagocytic marker). The target cells can be, for example, endothelial cells, tumor cells, leukocytes, or virus-infected cells. In certain embodiments of the invention the tagging is accomplished by administering a composition comprising an antibody or ligand linked to the phagcytotic marker, wherein the antibody or ligand binds to a cell type specific marker present on or in the cell surface of a target cell. In preferred embodiments of the invention, the phagocytic marker comprises phosphatidylserine or a group derived from phosphatidylserine, thrombospondin-1, annexin I, or a derivative of any of these.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.